Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Upstream Bio (UPB) Operating Expenses (2023 - 2025)

Historic Operating Expenses for Upstream Bio (UPB) over the last 3 years, with Q3 2025 value amounting to $38.5 million.

  • Upstream Bio's Operating Expenses rose 9752.31% to $38.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $143.3 million, marking a year-over-year increase of 11080.42%. This contributed to the annual value of $80.1 million for FY2024, which is 8857.72% up from last year.
  • As of Q3 2025, Upstream Bio's Operating Expenses stood at $38.5 million, which was up 9752.31% from $45.3 million recorded in Q2 2025.
  • In the past 5 years, Upstream Bio's Operating Expenses ranged from a high of $45.3 million in Q2 2025 and a low of $10.0 million during Q3 2023
  • In the last 3 years, Upstream Bio's Operating Expenses had a median value of $19.5 million in 2024 and averaged $24.6 million.
  • In the last 5 years, Upstream Bio's Operating Expenses soared by 8221.24% in 2024 and then skyrocketed by 15088.09% in 2025.
  • Upstream Bio's Operating Expenses (Quarter) stood at $14.8 million in 2023, then soared by 82.21% to $26.9 million in 2024, then surged by 43.02% to $38.5 million in 2025.
  • Its Operating Expenses stands at $38.5 million for Q3 2025, versus $45.3 million for Q2 2025 and $32.6 million for Q1 2025.